Letzte Aktualisierung: March 17, 2021
Two mRNA vaccines in development
China's ambition to one day be on a par with the EU and the US in terms of technology also affects biomedicine. Rather unnoticed by the public, two groups are working on vaccinations based on mRNA technology, which is considered the front line of modern disease control. The vaccine produced by Biontech, the majority of which is used in Germany, also uses mRNA. In the long term, China wants to enter the development and production of corresponding drugs on a large scale and become independent of the West in this area as well.